AURA
Aura Biosciences Inc
6.10$
+0.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +41.9% | -7.9% | -7.1% | -5.9% | -11.1% | -14.9% | +31.5% | -7.0% | -10.8% | -18.7% | +152.9% | |
| – | +50.6% | -8.4% | -7.8% | -6.2% | -12.5% | -16.3% | +36.8% | -7.5% | -12.0% | -20.9% | +177.7% | |
| – | -26.1% | -36.0% | +14.4% | -15.5% | +24.7% | +20.6% | +180.9% | -55.7% | +25.2% | +42.5% | -20.0% | |
| – | +51.7% | -10.3% | -7.6% | -7.0% | -13.4% | -15.3% | +38.5% | -8.7% | -10.9% | -20.5% | +182.3% | |
| – | +4.2% | -10.2% | +2.2% | +14.3% | -0.5% | -10.1% | +8.5% | +12.1% | -2.5% | -6.4% | +8.0% | |
| – | +13.4% | -21.8% | +9.2% | +39.5% | +1.4% | -18.4% | +22.1% | +26.7% | -2.3% | -9.1% | +17.1% | |
| – | -11.5% | +2.0% | +0.5% | +13.5% | +0.7% | +0.7% | +0.8% | +0.8% | +0.7% | +0.7% | +0.8% | |
| – | +19.9% | +8.2% | -24.5% | +36.5% | +15.7% | -12.9% | -35.9% | +46.8% | -18.0% | +66.1% | -12.4% | |
| – | +48.9% | -7.6% | -8.3% | -8.8% | -13.0% | -15.8% | +36.5% | -10.3% | -12.6% | -21.7% | +194.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +16.4% | +11.3% | +0.2% | +0.2% | 0.0% | +1.0% | +15.7% | +13.7% | -8.5% | +11.8% | +40.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.